Key Insights

Highlights

Success Rate

89% trial completion (above average)

Published Results

23 trials with published results (12%)

Research Maturity

89 completed trials (47% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

5.8%

11 terminated out of 190 trials

Success Rate

89.0%

+2.4% vs benchmark

Late-Stage Pipeline

7%

14 trials in Phase 3/4

Results Transparency

26%

23 of 89 completed with results

Key Signals

23 with results89% success11 terminated

Data Visualizations

Phase Distribution

97Total
Not Applicable (48)
Early P 1 (5)
P 1 (18)
P 2 (12)
P 3 (5)
P 4 (9)

Trial Status

Completed89
Recruiting35
Unknown22
Not Yet Recruiting13
Active Not Recruiting12
Terminated11

Trial Success Rate

89.0%

Benchmark: 86.6%

Based on 89 completed trials

Clinical Trials (190)

Showing 20 of 20 trials
NCT07810309Phase 1RecruitingPrimary

Metabolic Impact of Pancreatic Duct Decompression

NCT06205342Early Phase 1RecruitingPrimary

Safety and Efficacy of Mesenchymal Stem Cells Associated With Chronic Pancreatitis Pain

NCT07174609Not ApplicableRecruiting

Scrambler Therapy in Chronic Pancreatitis

NCT03324698Active Not RecruitingPrimary

The Natural History of Chronic Pancreatitis

NCT05692596Active Not Recruiting

The Pancreas Interception Center (PIC) for Early Detection, Prevention, and Novel Therapeutics

NCT07418593Phase 4RecruitingPrimary

Malabsorption Blood Test (MBT) to Determine Exocrine Pancreatic Function and Related Quality of Life in Chronic Pancreatitis

NCT03434392Not ApplicableRecruitingPrimary

QST Study: Predicting Treatment Response in Chronic Pancreatitis Using Quantitative Sensory Testing

NCT04996628Not ApplicableRecruitingPrimary

Pancreatic Quantitative Sensory Testing (P-QST) to Predict Treatment Response for Pain in Chronic Pancreatitis

NCT06651580RecruitingPrimary

Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study

NCT05095532Phase 1Active Not RecruitingPrimary

Autologous Mesenchymal Stromal Cells and Islet Co-transplantation in TP-IAT

NCT03460769Active Not Recruiting

Evaluation of a Mixed Meal Test for Diagnosis and Characterization and Type 3c Diabetes Mellitus Secondary to Pancreatic Cancer and Chronic Pancreatitis (DETECT)

NCT07770412Not Yet RecruitingPrimary

The Biobank Integrating Longitudinal ERCP Within a Prospective Chronic Pancreatitis Cohort

NCT07762950Not Yet RecruitingPrimary

Blood Biomarkers and Gut Microbiota for Pancreatic Cancer Risk in Chronic Pancreatitis

NCT07755813Phase 2Not Yet RecruitingPrimary

Pirfenidone as Treatment of Chronic Pancreatitis

NCT05664880Early Phase 1Active Not RecruitingPrimary

A PiLot ClinicaL TrIal of ParicAlcitol for ChroNiC PancrEatitis

NCT05771675Early Phase 1Recruiting

Simvastatin Treatment to Improve Patient-reported Outcomes in Patients With Chronic Pancreatitis

NCT06362187Not ApplicableNot Yet RecruitingPrimary

VR Pilot for Pancreatitis

NCT06386224Not ApplicableRecruiting

Internet-Delivered Pain Self-Management for Persons With Acute Recurrent and Chronic Pancreatitis Pain

NCT07707609RecruitingPrimary

Neural Sensitisation and Neuropsychological Alterations in Painful Chronic Pancreatitis

NCT07696572Recruiting

EUS Procedures Using RIVOS™ EUS Access Device

Scroll to load more

Research Network

Activity Timeline